MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ANNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Annexon (ANNX) Ownership - Who owns Annexon?

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
96
Web
https://www.annexonbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
861.81M
P/E Ratio
N/A
Total Cash
225.03M
Projected Growth
N/A
Total Debt
25.43M
Revenue
N/A
Risk (Beta)
2.72
Dividend Yield
N/A
Total Cash/Share
1.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ANNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ANNX
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
96
Web
https://www.annexonbio.com